Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: Nested case-control study

Circulation

Volumn 106, Issue 21, 2002, Pages 2659-2665

  Brunner, E J ^a   Hemingway, H ^a   Walker, B R ^a,b   Page, M ^a   Clarke, P ^a   Juneja, M ^a   Shipley, M J ^a   Kumari, M ^a   Andrew, R ^a,b   Seckl, J R ^a,b   Papadopoulos, A ^a,c   Checkley, S ^a,c   Rumley, A ^a,d   Lowe, G D O ^a,d   Stansfeld, S A ^a,e   Marmot, M G ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Coronary disease; Heart rate; Metabolism; Norepinephrine; Stress

Indexed keywords

C REACTIVE PROTEIN; CATECHOLAMINE; HYDROCORTISONE DERIVATIVE; INTERLEUKIN 6; NORMETADRENALIN;

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLOOD VISCOSITY; CASE CONTROL STUDY; CONTROLLED STUDY; HEALTH BEHAVIOR; HEART INNERVATION; HEART RATE VARIABILITY; HORMONE SENSITIVITY; HUMAN; HYDROCORTISONE RELEASE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NEUROENDOCRINE SYSTEM; PRIORITY JOURNAL; SOCIAL PSYCHOLOGY; STRESS; SYMPATHETIC TONE;

ADRENAL CORTEX; AUTONOMIC NERVOUS SYSTEM; BLOOD VISCOSITY; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CATECHOLAMINES; COHORT STUDIES; CORONARY RESTENOSIS; DOUBLE-BLIND METHOD; HEART RATE; HUMANS; HYDROCORTISONE; INFLAMMATION; INTERLEUKIN-6; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NEUROSECRETORY SYSTEMS; NORMETANEPHRINE; PSYCHOLOGY; STRESS;

EID: 0037137285     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000038364.26310.BD     Document Type: Article

References (31)

1. Marmot MG. Inequalities in health. N Engl J Med. 2001;345:134-136.
2. Marmot MG, Davey Smith G, Stansfeld SA, et al. Health inequalities among British civil servants: The Whitehall II study. Lancet. 1991;337:1387-1393.
3. Brunner EJ, Marmot MG, Nanchahal K, et al. Social inequality in coronary risk: Central obesity and the metabolic syndrome: Evidence from the WII study. Diabetologia. 1997;40:1341-1349.
4. Sakkinen PA, Wahl P, Cushman M, et al. Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. Am J Epidemiol. 2000;152:897-907.
5. Brunner EJ, Davey Smith G, Marmot MG, et al. Childhood social circumstances and psychosocial and behavioural factors as determinants of plasma fibrinogen. Lancet. 1996;347:1008-1013.
6. Brunner EJ. Stress and the biology of inequality. BMJ. 1997;314:1472-1476.
7. Marmot M, Bosma H, Hemingway H, et al. Contribution of job control and other risk factors to social variations in coronary heart disease incidence: Whitehall II Study. Lancet. 1997;350:235-239.
8. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities: The role of insulin resistance and the sympathoadrenal system. N Engl J Med. 1996;334:374-381.
9. Liao D, Sloan RP, Cascio WE, et al. Multiple metabolic syndrome is associated with lower heart rate variability: ARIC study. Diabetes Care. 1998;21:2116-2122.
10. Phillips DIW, Barker DJP, Fall CHD, et al. Elevated plasma cortisol concentrations: A link between low birth weight and insulin resistance syndrome? J Clin Endocrinol Metab. 1998;83:757-760.
11. Andrew R, Phillips DIW, Walker BR. Obesity and gender influence cortisol secretion and metabolism in men. J Clin Endocrinol Metab. 1998;83:1806-1809.
12. Berne C, Fagius J, Pollare T, et al. The sympathetic response to euglycaemic hyperinsulinaemia. Diabetologia. 1992;35:873-879.
13. Bjorntorp P, Holm G, Rosmond R. Hypothalamic arousal, insulin resistance and type 2 diabetes mellitus. Diabetes Med. 1999;16:373-383.
14. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
15. Beam J, Buntwal N, Papadopoulos A, et al. Saliva cortisol during opiate dependence and withdrawal. Addict Biol. 2001;6:157-162.
16. Walker BR, Phillips DI, Noon JP, et al. Increased glucocorticoid activity in men with cardiovascular risk factors. Hypertension. 1998;31:891-895.
17. Yarnell JW, Sweetnam PM, Rumley A, et al. Lifestyle and hemostatic risk factors for ischemic heart disease: Caerphilly study. Arterioscler Thromb Vasc Biol. 2000;20:271-279.
18. Taskforce of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: Standards of measurement, physiological interpretation and clinical use. Circulation. 1996;93:1043-1065.
19. Schafer JL. Analysis of Incomplete Multivariate Data. London: Chapman and Hall; 1997.
20. Kuper H, Marmot MG. Decision latitude, job demands, job strain and risk of coronary heart disease within the Whitehall II study. J Epidemiol Commun Health. In press.
21. Hemingway H, Marmot M. Psychosocial factors in the aetiology and prognosis of CHD: Systematic review of prospective cohort studies. BMJ. 1999;318:1460-1467.
22. Yudkin JS, Kumari M, Humphries SE, et al. Inflammation, obesity, stress and coronary heart disease: Is interleukin-6 the link? Atherosclerosis. 2000;148:209-214.
23. Kawachi I, Sparrow D, Vokonas PS, et al. Decreased heart rate variability in men with phobic anxiety. Am J Cardiol. 1995;75:882-885.
24. Hemingway H, Malik M, Marmot M. Social and psychosocial influences on sudden cardiac death, ventricular arrhythmia and cardiac autonomic function. Eur Heart J. 2001;22:1082-1101.
25. Liao D, Cai J, Rosamond WD, et al. Cardiac autonomic function and incident coronary heart disease: A population-based case-cohort study: ARIC Study. Am J Epidemiol. 1997:145:696-706.
26. Curtin F, Walker JP, Schulz P. Day-to-day intraindividual reliability and interindividual differences in monoamines excretion. J Affect Disord. 1996;38:173-178.
27. Duncan BB, Schmidt MI, Chambless LE, et al. Fibrinogen, other putative markers of inflammation, and weight gain in middle-aged adults: ARIC study. Obes Res. 2000;8:279-286.
28. Schmidt MI, Duncan BB, Sharrett AR, et al. Markers of inflammation and prediction of diabetes mellitus in adults: ARIC study. Lancet. 1999;353:1649-1652.
29. Danesh J, Collins R, Appleby P, et al. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with CHD. JAMA. 1998;279:1477-1481.
30. Von Kanel R, Mills PJ, Fainman C, et al. Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis: A biobehavioral pathway to CAD. Psychosom Med. 2001;63:531-544.
31. McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med. 1998;338:171-179.